Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabo-lipidomics of Fibroblasts and Mitochondrial-Endoplasmic Reticulum Extracts from ALS Patients Shows Alterations in Purine, Pyrimidine, Energetic, and Phospholipid Metabolisms
Charlotte Veyrat‐Durebex, Céline Bris, Philippe Codron, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5780-5791
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis
Adriano B. Chaves‐Filho, Isabella Fernanda Dantas Pinto, Lucas S. Dantas, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 126
The expanding organelle lipidomes: current knowledge and challenges
Maria J. Sarmento, Alicia Llorente, Toni Petan, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 8
Open Access | Times Cited: 22
Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
Estela Área-Gómez, Delfina Larrea, Tianwei Yun, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine
Ira Agrawal, Yong Shan Lim, Shi‐Yan Ng, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts
Stephen A. Goutman, Kai Guo, Masha G. Savelieff, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4425-4439
Open Access | Times Cited: 31
Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis
Thibaut Burg, Elisabeth Rossaert, Matthieu Moisse, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11224-11224
Open Access | Times Cited: 39
The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis
Alessia Serrano, Savina Apolloni, Simona Rossi, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1261-1261
Open Access | Times Cited: 39
Effects of PB‐TURSO on the transcriptional and metabolic landscape of sporadic ALS fibroblasts
Jasmine A. Fels, Jalia Dash, Kent Leslie, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1551-1564
Open Access | Times Cited: 21
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis
Hélène Blasco, Débora Lanznaster, Charlotte Veyrat‐Durebex, et al.
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 9, pp. 907-919
Closed Access | Times Cited: 31
Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research
Beatriz Pinto Ribeiro de Araujo, Luiz Silva, Jorge Torresi, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 12, pp. 5084-5102
Open Access | Times Cited: 28
Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship
Niccolò Candelise, Illari Salvatori, Silvia Scaricamazza, et al.
Metabolites (2022) Vol. 12, Iss. 3, pp. 233-233
Open Access | Times Cited: 17
Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics
Jarosław Walczak, Grażyna Dębska‐Vielhaber, Stefan Vielhaber, et al.
The FASEB Journal (2018) Vol. 33, Iss. 3, pp. 4388-4403
Open Access | Times Cited: 28
Autophagy protein 5 controls flow-dependent endothelial functions
Pierre Nivoit, Thomas Mathivet, Junxi Wu, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 8
Open Access | Times Cited: 8
Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts
Margarita Gerou, Benjamin Hall, Ryan Woof, et al.
Neurobiology of Aging (2021) Vol. 105, pp. 64-77
Open Access | Times Cited: 20
Abnormal energy metabolism in ALS: a key player?
Thibaut Burg, Ludo Van Den Bosch
Current Opinion in Neurology (2023) Vol. 36, Iss. 4, pp. 338-345
Open Access | Times Cited: 7
Mitochondria-ER Tethering in Neurodegenerative Diseases
Reza Raeisossadati, M Ferrari
Cellular and Molecular Neurobiology (2020) Vol. 42, Iss. 4, pp. 917-930
Closed Access | Times Cited: 18
The Mitochondrial-associated ER membrane (MAM) compartment and its dysregulation in Amyotrophic Lateral Sclerosis (ALS)
Sonam Parakh, Julie D. Atkin
Seminars in Cell and Developmental Biology (2021) Vol. 112, pp. 105-113
Closed Access | Times Cited: 17
Changes in metabolomics and lipidomics in brain tissue and their correlations with the gut microbiome after chronic food-derived arsenic exposure in mice
Chenfei Wang, Hongyu Deng, Dongbin Wang, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 228, pp. 112935-112935
Open Access | Times Cited: 16
Glutamate-Induced Deregulation of Krebs Cycle in Mitochondrial Encephalopathy Lactic Acidosis Syndrome Stroke-Like Episodes (MELAS) Syndrome Is Alleviated by Ketone Body Exposure
Sophie Belal, David Goudenège, Cinzia Bocca, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1665-1665
Open Access | Times Cited: 12
High-Coverage Strategy for Multi-Subcellular Metabolome Analysis Using Dansyl-Labeling-Based LC-MS/MS
Siyuan Qin, Meiyu Gao, Qiqing Zhang, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 26, pp. 10034-10043
Closed Access | Times Cited: 6
Gene expression profiles in sporadic ALS fibroblasts define disease subtypes and the metabolic effects of the investigational drug EH301
Jasmine A. Fels, Gabriella Casalena, Csaba Konràd, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 20, pp. 3458-3477
Open Access | Times Cited: 9
Protection from the Pathogenesis of Neurodegenerative Disorders, including Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Huntington’s Disease, and Parkinson’s Diseases, through the Mitigation of Reactive Oxygen Species
Sahithi Madireddy, Samskruthi Madireddy
Journal of Neuroscience and Neurological Disorders (2019) Vol. 3, Iss. 2, pp. 148-161
Open Access | Times Cited: 14
Subcellular metabolomics: Isolation, measurement, and applications
Siyuan Qin, Yuxin Zhang, Yuan Tian, et al.
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 210, pp. 114557-114557
Closed Access | Times Cited: 11
From use of omics to systems biology: Identifying therapeutic targets for amyotrophic lateral sclerosis
Lydia M. Castelli, Rosario Vasta, Scott P. Allen, et al.
International review of neurobiology (2024), pp. 209-268
Closed Access | Times Cited: 1
Existing and Emerging Metabolomic Tools for ALS Research
Christine Germeys, Tijs Vandoorne, Valérie Bercier, et al.
Genes (2019) Vol. 10, Iss. 12, pp. 1011-1011
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top